Search

Home > The Journal. > The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
Podcast: The Journal.
Episode:

The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
Category: News & Politics
Duration: 00:24:26
Publish Date: 2025-03-21 20:20:00
Description:

After it was approved in 2019, Spravato, a depression treatment derived from the club drug ketamine, was looking like a dud. But recently it has taken off, and it surpassed $1 billion in annual sales last year for its maker, Johnson and Johnson.


Further Listening:

-A Lawyer Says He Doesn't Need Help for Psychosis. His Family Disagrees. 

-America's Maternal Mental Health Crisis 


Further Reading:

-J&J’s Ketamine-Derived Drug Is Taking Off 

-Big Pharma Walked Away From Mental Health. Why Some Are Coming Back. 


Learn more about your ad choices. Visit megaphone.fm/adchoices
Total Play: 0

Some more Podcasts by The Wall Street Journal

1K+ Episodes
WSJ Opinion: .. 600+     90+
200+ Episodes
WSJ Secrets .. 50+     1
300+ Episodes
WSJ The Futu .. 40+     10+
3K+ Episodes
WSJ Tech New .. 20+     20+
20+ Episodes
WSJ Minute B .. 70+     1
500+ Episodes
WSJ What's N .. 100+     10+
1K+ Episodes
WSJ Your Mon .. 10+     3
2K+ Episodes
WSJ What’s ..     6